MLMIC’s analysis of chief medical factors associated with improper performance shows that multiple specialties are involved and different types of procedures are triggering lawsuits.
The U.S. Food and Drug Administration issued an emergency use authorization for simultaneous administration of monoclonal antibodies bamlanivimab and etesevimab to treat COVID-19 patients who meet specific criteria.
Guidance published by Oregon Health & Science University scientists outlines a preoperative protocol for surgical care teams to evaluate the readiness of previously COVID-positive patients for elective procedures.
A properly selected telehealth system can provide an effective format for healthcare delivery absent an in-person visit. Physicians are advised to consider a number of factors when determining if telehealth technology will benefit their practice and patients.